CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING

by NASDAQ Market News April 21, 2020

NASDAQ Market News
Click here to email author

Myovant Sciences Submits New Drug Application (NDA) to the FDA for Once-Daily, Oral Relugolix for the Treatment of Men with Advanced Prostate Cancer

Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2020 DDW Annual Meeting

Ads